Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Landos Biopharma
Landos Biopharma
AbbVie to bolster immunity illness drug pipeline with Landos buy
Yahoo/Reuters
Mon, 03/25/24 - 11:39 am
AbbVie
Landos Biopharma
immune disorders
M&A
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Fierce Biotech
Mon, 05/17/21 - 10:44 am
LianBio
Landos Biopharma
IPOs
ulcerative colitis
Crohn's Disease
China
Asia
Life Sciences Companies Ringing the Nasdaq Bell this Week
BioSpace
Thu, 02/4/21 - 08:10 pm
IPOs
NASDAQ
Sana Biotechnology
Sensei Biotherapeutics
Landos Biopharma
Aspira Women's Health
Equillium
Will Murky Trial Data Undercut Landos' $100 Million IPO Launch?
BioSpace
Thu, 01/14/21 - 10:30 pm
Landos Biopharma
IPOs
$60M B round to propel Landos through Phase II IBD trials
BioCentury
Wed, 08/14/19 - 11:07 am
Landos Biopharma
clinical trials
ulcerative colitis
Crohn's Disease
BT-11
Landos Biopharma Initiates Ph I Trial of First-in-class Oral Treatment for IBD
Thu, 07/12/18 - 09:17 am
Landos Biopharma
ulcerative colitis
Chron's Disease
IBD
BT-11